2m 2m 2m 2m 2m 2m 2m
REGENXBIO (RGNX)
NASDAQ
$12.58-$0.17 (-1.34%)
Price as of Jul 14, 2026 5:46 AM EDT- $659.1MMarket Cap
- 46.55%1-Year Change
- BiotechnologyIndustry
REGENXBIO (RGNX)
$12.58-$0.17 (-1.34%)
RGNX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.75 | ||
Change | -$1.20 (-8.60%) | ||
Open | $13.56 | ||
High | $13.56 | ||
Low | $12.19 | ||
Previous Close | $13.95 | ||
Volume | 2,184,641 | ||
30-Day Average Volume | 3,102,214 | ||
1-Week Change | -14.03% | ||
1-Month Change | 91.44% | ||
1-Year Change | 46.55% | ||
3-Year Change | -33.14% | ||
5-Year Change | -65.08% | ||
Fundamentals | |||
Shares Outstanding | 51.7M | ||
Total Assets | $341.9M | ||
Market Cap | $659.1M | ||
Enterprise Value | $643.9M | ||
Period: QTR TTM FY | |||
Revenue | $5.1M | ||
Net Income | -$90.1M | ||
Free Cash Flow | -$77.4M | ||
EBIT | $102.4M | ||
EBITDA | $106.3M | ||
Net Working Capital | $115.4M | ||
EPS | -$1.72 | ||
Enterprise Value/EBITDA | 6 | ||
Enterprise Value/Revenue | 127 | ||
P/B | 31 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue